We are entrepreneurial scientists dedicated to maximizing value. Our team continuously envisions opportunity in unexplored spaces and realizes value for society through disruptive innovations and ventures.
Latest Press from Flagship Pioneering
- Growth at Flagship Pioneering Leads to New Executive Appointments 05.28.2019
- MIT Solve Announces Launch of Solve Innovation Fund 05.07.2019
- Flagship Pioneering Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer 04.16.2019
- Flagship Pioneering Expands Growth Capabilities, Announces Capital Raise of $824MM 03.20.2019
- Foghorn® Therapeutics Appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer 12.13.2018
- Flagship Pioneering Names Ryan Watts, CEO of Denali Therapeutics, as Recipient of the 2018 Pioneering Leader Award 11.15.2018